Dr Meyer-Rath is a Research Associate Professor at the Department of Global Health of the Boston University School of Public Health. She is a physician and health economist working on the economics of HIV and COVID-19 in low- and middle-income countries. Her focus lies on modeling methods for economic evaluation, including infectious disease modeling and decision analysis, and translating research into recommendations for public policy. Before joining BUSPH she has worked in the Pediatrics Department of Charité University Hospital Berlin, at the World Health Organization and at the London School of Hygiene and Tropical Medicine.
Dr Meyer-Rath is based in Johannesburg where she works at the Health Economics and Epidemiology Research Office (HE2RO), a collaboration between Boston University and the University of the Witwatersrand. She holds a PhD in Health Economics from the London School of Hygiene and Tropical Medicine as well as a MD/PhD in Physiology from Free University Berlin.
Diversity, Equity, Inclusion and Accessibility
Early this year I was invited to co-chair a conference session on "Decolonising Health Economics" at the International Health Economics Association Conference. I tried to refuse, not thinking that as a highly privileged German national I could do the subject justice, but my co-chair, a Malawian health economist who I had mentored through her PhD, insisted. She invited me to talk about HE2RO's experience in building sustained academic health economics capacity in a middle-income country. This started my journey towards more consciously centering local, in particular first generation, staff in all activities. The notes under "Ad 7" above are in part a summary of that endeavour; of the four mentees mentioned, all are South African, two are previously disadvantaged, and all are first generation academics. Being involved in a first pan-African research project, the "UHCDigital" project funded by the German Research Foundation (DFG) continued the theme of making space (in brief, shutting up and stepping aside). Lastly, thinking through what kind of health modelling institute we want to build extended the theme of capacity building. I do believe we need to collectively move from building capacity individually, one-at-a-time, depending on our time and budget (there's a reason why "Capacity building" most often comes last in any funding proposal), towards helping to co-design, then build local institutions- then, once it is up and running, getting out. My joining the BUSPH DEIJ at the beginning of 2022 continues this journey.
Center Faculty Member
Boston University School of Public Health
Global Health
This tab shows grant data from BMC Sponsored Research. It includes:
- Grant title
- Project period and this person’s role on the grant
- PI name, if this person is not the PI (the name will link if PI has a BU Profile)
- Funding source(s). An arrow indicates the flow of funding if multiple sponsors.
- Some grants will show an agency award/project number, and may be a link.
- Data is sorted by project end date, and updated monthly.
This tab shows grant data from BU Sponsored Research. It includes:
- Grant title
- Project period and this person’s role on the grant
- PI name, if this person is not the PI (the name will link if PI has a BU Profile)
- Funding source(s). An arrow indicates the flow of funding if multiple sponsors.
- Some grants will show an agency award/project number, and may be a link.
- Data is sorted by project end date, and updated monthly.
This tab shows grant data that did not automatically get imported into Profiles
from BU or BMC sources.
- Grant title
- Project period and this person’s role on the grant
- PI name, if this person is not the PI (the name will link if PI has a BU Profile)
- Funding source(s). An arrow indicates the flow of funding if multiple sponsors.
- Some grants will show an agency award/project number, and may be a link.
- Data is sorted by project end date, and updated monthly.
This tab shows grant data from the Boston VA. We are only showing grant title, and only for people in the role of PI.
HIV and TB estimation, mathematical modelling, and economic analysis to support national and sub-national HIV policy setting in South Africa09/30/2020 - 12/31/2023 (Subcontract PI)
University of Cape Town Bill & Melinda Gates
To Support a consortium of modelers to inform the planning of HIV programs in Sub-Saharan Africa to understand the impact of current and future interventions10/01/2021 - 09/30/2023 (Subcontract PI)
WITS Health Consortium (PTY) LTD Bill & Melinda Gates
COVID-19 priority vaccine modelling for South Africa and beyond08/12/2021 - 01/31/2023 (Subcontract PI)
WITS Health Consortium (PTY) LTD Bill & Melinda Gates
Rapid Screening for Complex Chronic Conditions (Taxi Rank project)07/01/2021 - 11/30/2022 (Multi-PI)
PI:
Gesine Meyer-Rath, MD, PhDFoundation for Innovative New Diagnostics (FIND)
Economic Impact of HIV Policy Briefs11/14/2019 - 04/30/2022 (PI)
Bill and Melinda Gates Foundation
Enhancing the evidence-base for HIV self-testing in young men04/17/2018 - 12/31/2020 (Subcontract PI)
WITS Health Consortium (PTY) LTD Bill & Melinda Gates
Prospective costing exercises for HIV in high prevalence countries01/01/2020 - 10/30/2020 (Subcontract PI)
President & Fellows of Harvard College on behalf of Harvard Medical School Bill & Melinda Gates
Identifying optimal HIV testing strategies to achieve high levels of HIV diagnosis in South Africa09/01/2016 - 07/31/2017 (Subcontract PI)
Imperial College Bill & Melinda Gates
|
Yr
|
Title
|
Project-Sub Proj
|
Pubs
|
Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
login
to make corrections and additions.
-
Brennan AT, Vetter B, Majam M, T Msolomba V, Venter F, Carmona S, Kao K, Gordon A, Meyer-Rath G. Integration of point-of-care screening for type 2 diabetes mellitus and hypertension with COVID-19 rapid antigen screening in Johannesburg, South Africa. PLoS One. 2023; 18(7):e0287794.View Related Profiles. PMID: 37418394; PMCID: PMC10328308; DOI: 10.1371/journal.pone.0287794;
-
-
Meyer-Rath G, Jamieson L, Pillay Y. What will it take for an injectable ARV to change the face of the HIV epidemic in high-prevalence countries? Considerations regarding drug costs and operations. J Int AIDS Soc. 2023 Jul; 26 Suppl 2(Suppl 2):e26106. PMID: 37439062; PMCID: PMC10338998; DOI: 10.1002/jia2.26106;
-
Zishiri V, Conserve DF, Haile ZT, Corbett E, Hatzold K, Meyer-Rath G, Matsimela K, Sande L, d'Elbee M, Terris-Prestholt F, Johnson CC, Chidarikire T, Venter F, Majam M. Secondary distribution of HIV self-test kits by HIV index and antenatal care clients: implementation and costing results from the STAR Initiative in South Africa. BMC Infect Dis. 2023 Jun 01; 22(Suppl 1):971. PMID: 37264343; PMCID: PMC10234581; DOI: 10.1186/s12879-023-08324-7;
-
Jamieson L, Van Schalkwyk C, Nichols BE, Meyer-Rath G, Silal S, Pulliam J, Blumberg L, Cohen C, Moultrie H, Jassat W. Differential in-hospital mortality and intensive care treatment over time: Informing hospital pathways for modelling COVID-19 in South Africa. PLOS Glob Public Health. 2023; 3(5):e0001073.View Related Profiles. PMID: 37195977; PMCID: PMC10191304; DOI: 10.1371/journal.pgph.0001073;
-
Silal SP, Pulliam JRC, Meyer-Rath G, Jamieson L, Nichols BE, Norman J, Hounsell R, Mayet S, Kagoro F, Moultrie H. The National COVID-19 Epi Model (NCEM): Estimating cases, admissions and deaths for the first wave of COVID-19 in South Africa. PLOS Glob Public Health. 2023; 3(4):e0001070.View Related Profiles. PMID: 37093784; PMCID: PMC10124849; DOI: 10.1371/journal.pgph.0001070;
-
Long LC, Girdwood S, Govender K, Meyer-Rath G, Miot J. Cost and outcomes of routine HIV care and treatment: public and private service delivery models covering low-income earners in South Africa. BMC Health Serv Res. 2023 Mar 11; 23(1):240.View Related Profiles. PMID: 36906559; PMCID: PMC10007767; DOI: 10.1186/s12913-023-09147-7;
-
Smith J, Bansi-Matharu L, Cambiano V, Dimitrov D, Bershteyn A, van de Vijver D, Kripke K, Revill P, Boily MC, Meyer-Rath G, Taramusi I, Lundgren JD, van Oosterhout JJ, Kuritzkes D, Schaefer R, Siedner MJ, Schapiro J, Delany-Moretlwe S, Landovitz RJ, Flexner C, Jordan M, Venter F, Radebe M, Ripin D, Jenkins S, Resar D, Amole C, Shahmanesh M, Gupta RK, Raizes E, Johnson C, Inzaule S, Shafer R, Warren M, Stansfield S, Paredes R, Phillips AN. Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study. Lancet HIV. 2023 Apr; 10(4):e254-e265. PMID: 36642087; PMCID: PMC10065903; DOI: 10.1016/S2352-3018(22)00365-4;
-
Bansi-Matharu L, Mudimu E, Martin-Hughes R, Hamilton M, Johnson L, Ten Brink D, Stover J, Meyer-Rath G, Kelly SL, Jamieson L, Cambiano V, Jahn A, Cowan FM, Mangenah C, Mavhu W, Chidarikire T, Toledo C, Revill P, Sundaram M, Hatzold K, Yansaneh A, Apollo T, Kalua T, Mugurungi O, Kiggundu V, Zhang S, Nyirenda R, Phillips A, Kripke K, Bershteyn A. Cost-effectiveness of voluntary medical male circumcision for HIV prevention across sub-Saharan Africa: results from five independent models. Lancet Glob Health. 2023 Feb; 11(2):e244-e255. PMID: 36563699; PMCID: PMC10005968; DOI: 10.1016/S2214-109X(22)00515-0;
-
Masuku SD, Lekodeba N, Meyer-Rath G. The costs of interventions for type 2 diabetes mellitus, hypertension and cardiovascular disease in South Africa - a systematic literature review. BMC Public Health. 2022 Dec 12; 22(1):2321. PMID: 36510178; PMCID: PMC9743545; DOI: 10.1186/s12889-022-14730-4;
Showing 10 of 77 results.
Show More
-
Jamieson L, Johnson LF, Nichols BE, Delany-Moretlwe S, Hosseinipour MC, Russell C, Meyer-Rath G. Relative cost-effectiveness of long-acting injectable cabotegravir versus oral pre-exposure prophylaxis in South Africa based on the HPTN 083 and HPTN 084 trials: a modelled economic evaluation and threshold analysis. Lancet HIV. 2022 Dec; 9(12):e857-e867.View Related Profiles. PMID: 36356603; PMCID: PMC9708606; DOI: 10.1016/S2352-3018(22)00251-X;
-
Benade M, Long L, Meyer-Rath G, Miot J, Evans D, Tucker JM, Moultrie H, Rosen S. Reduction in initiations of drug-sensitive tuberculosis treatment in South Africa during the COVID-19 pandemic: Analysis of retrospective, facility-level data. PLOS Glob Public Health. 2022; 2(10):e0000559.View Related Profiles. PMID: 36962535; PMCID: PMC10021649; DOI: 10.1371/journal.pgph.0000559;
-
Benade M, Long L, Meyer-Rath G, Miot J, Evans D, Tucker JM, Moultrie H, Rosen S. Reduction in initiations of drug-sensitive tuberculosis treatment in South Africa during the COVID-19 pandemic: Analysis of retrospective, facility-level data. PLOS Glob Public Health. 2022; 2(10):e0000559.View Related Profiles. PMID: 36962535; PMCID: PMC10021649; DOI: 10.1371/journal.pgph.0000559;
-
Bershteyn A, Jamieson L, Kim HY, Platais I, Milali MP, Mudimu E, Ten Brink D, Martin-Hughes R, Kelly SL, Phillips AN, Bansi-Matharu L, Cambiano V, Revill P, Meyer-Rath G, Nichols BE. Transmission reduction, health benefits, and upper-bound costs of interventions to improve retention on antiretroviral therapy: a combined analysis of three mathematical models. Lancet Glob Health. 2022 09; 10(9):e1298-e1306.View Related Profiles. PMID: 35961353; PMCID: PMC9380252; DOI: 10.1016/S2214-109X(22)00310-2;
-
Silal SP, Groome MJ, Govender N, Pulliam JRC, Ramadan OP, Puren A, Jassat W, Leonard E, Moultrie H, Meyer-Rath KG, Ramkrishna W, Langa T, Furumele T, Moonasar D, Cohen C, Walaza S. Leveraging epidemiology as a decision support tool during the COVID-19 epidemic in South Africa. S Afr Med J. 2022 May 31; 112(5b):361-365. PMID: 35783465; PMCID: PMC7612950; DOI: 10.7196/SAMJ.2022.v112i5b.16061;
-
Phillips AN, Bershteyn A, Revill P, Bansi-Matharu L, Kripke K, Boily MC, Martin-Hughes R, Johnson LF, Mukandavire Z, Jamieson L, Meyer-Rath G, Hallett TB, Ten Brink D, Kelly SL, Nichols BE, Bendavid E, Mudimu E, Taramusi I, Smith J, Dalal S, Baggaley R, Crowley S, Terris-Prestholt F, Godfrey-Faussett P, Mukui I, Jahn A, Case KK, Havlir D, Petersen M, Kamya M, Koss CA, Balzer LB, Apollo T, Chidarikire T, Mellors JW, Parikh UM, Godfrey C, Cambiano V. Cost-effectiveness of easy-access, risk-informed oral pre-exposure prophylaxis in HIV epidemics in sub-Saharan Africa: a modelling study. Lancet HIV. 2022 May; 9(5):e353-e362.View Related Profiles. PMID: 35489378; PMCID: PMC9065367; DOI: 10.1016/S2352-3018(22)00029-7;
-
-
Johnson LF, Meyer-Rath G, Dorrington RE, Puren A, Seathlodi T, Zuma K, Feizzadeh A. The Effect of HIV Programs in South Africa on National HIV Incidence Trends, 2000-2019. J Acquir Immune Defic Syndr. 2022 Jun 01; 90(2):115-123. PMID: 35125471
-
Jamieson L, Serenata C, Makhubele L, Sokhela S, Mashabane N, Akpomiemie G, Johnson LF, Venter WDF, Meyer-Rath G. Cost and cost-effectiveness of dolutegravir-based antiretroviral regimens: an economic evaluation of a clinical trial. AIDS. 2021 12 15; 35(Suppl 2):S173-S182. PMID: 34848584
-
Murphy JP, Kgowedi S, Naidoo N, Girdwood S, Jamieson L, Soeteman D, Resch S, Meyer-Rath G. Role of data from cost and other economic analyses in healthcare decision-making for HIV, TB and sexual/reproductive health programmes in South Africa. Health Policy Plan. 2021 Nov 11; 36(10):1545-1551. PMID: 34212192; PMCID: PMC8597963; DOI: 10.1093/heapol/czab071;
-
-
Jamieson L, Johnson LF, Matsimela K, Sande LA, d'Elbée M, Majam M, Johnson C, Chidarikire T, Hatzold K, Terris-Prestholt F, Nichols B, Meyer-Rath G. The cost effectiveness and optimal configuration of HIV self-test distribution in South Africa: a model analysis. BMJ Glob Health. 2021 07; 6(Suppl 4).View Related Profiles. PMID: 34275876; PMCID: PMC8287627; DOI: 10.1136/bmjgh-2021-005598;
-
Sande LA, Matsimela K, Mwenge L, Mangenah C, Choko AT, d'Elbée M, Majam M, Mostert C, Matamwandi I, Sibanda EL, Johnson C, Hatzold K, Ayles H, Cowan FM, Corbett EL, Neuman M, Maheswaran H, Meyer-Rath G, Terris-Prestholt F. Costs of integrating HIV self-testing in public health facilities in Malawi, South Africa, Zambia and Zimbabwe. BMJ Glob Health. 2021 07; 6(Suppl 4). PMID: 34275874; PMCID: PMC8287606; DOI: 10.1136/bmjgh-2021-005191;
-
d'Elbée M, Gomez GB, Sande LA, Mwenge L, Mangenah C, Johnson C, Medley GF, Neuman M, Hatzold K, Corbett EL, Meyer-Rath G, Terris-Prestholt F. Modelling costs of community-based HIV self-testing programmes in Southern Africa at scale: an econometric cost function analysis across five countries. BMJ Glob Health. 2021 07; 6(Suppl 4). PMID: 34275875; PMCID: PMC8287624; DOI: 10.1136/bmjgh-2021-005554;
-
Long LC, Rosen S, Nichols B, Larson BA, Ndlovu N, Meyer-Rath G. Getting resources to those who need them: the evidence we need to budget for underserved populations in sub-Saharan Africa. J Int AIDS Soc. 2021 07; 24 Suppl 3:e25707.View Related Profiles. PMID: 34189873; PMCID: PMC8242975; DOI: 10.1002/jia2.25707;
-
Matsimela K, Sande LA, Mostert C, Majam M, Phiri J, Zishiri V, Madondo C, Khama S, Chidarikire T, d'Elbée M, Hatzold K, Johnson C, Terris-Prestholt F, Meyer-Rath G. The cost and intermediary cost-effectiveness of oral HIV self-test kit distribution across 11 distribution models in South Africa. BMJ Glob Health. 2021 07; 6(Suppl 4). PMID: 34275873; PMCID: PMC8287621; DOI: 10.1136/bmjgh-2021-005019;
-
Nichols BE, Jamieson L, Zhang SRC, Rao GA, Silal S, Pulliam JRC, Sanne I, Meyer-Rath G. The Role of Remdesivir in South Africa: Preventing COVID-19 Deaths Through Increasing Intensive Care Unit Capacity. Clin Infect Dis. 2021 05 04; 72(9):1642-1644.View Related Profiles. PMID: 32628744; PMCID: PMC7454458; DOI: 10.1093/cid/ciaa937;
-
Edoka I, Fraser H, Jamieson L, Meyer-Rath G, Mdewa W. Inpatient Care Costs of COVID-19 in South Africa's Public Healthcare System. Int J Health Policy Manag. 2022 Aug 01; 11(8):1354-1361. PMID: 33949817; PMCID: PMC9808349; DOI: 10.34172/ijhpm.2021.24;
-
Phillips AN, Cambiano V, Johnson L, Nakagawa F, Homan R, Meyer-Rath G, Rehle T, Tanser F, Moyo S, Shahmanesh M, Castor D, Russell E, Jamieson L, Bansi-Matharu L, Shroufi A, Barnabas RV, Parikh UM, Mellors JW, Revill P. Potential Impact and Cost-Effectiveness of Condomless-Sex-Concentrated PrEP in KwaZulu-Natal Accounting for Drug Resistance. J Infect Dis. 2021 04 23; 223(8):1345-1355. PMID: 31851759; PMCID: PMC8064039; DOI: 10.1093/infdis/jiz667;
-
Jo Y, Jamieson L, Edoka I, Long L, Silal S, Pulliam JRC, Moultrie H, Sanne I, Meyer-Rath G, Nichols BE. Cost-effectiveness of Remdesivir and Dexamethasone for COVID-19 Treatment in South Africa. Open Forum Infect Dis. 2021 Mar; 8(3):ofab040.View Related Profiles. PMID: 33732750; PMCID: PMC7928624; DOI: 10.1093/ofid/ofab040;
-
d'Elbée M, Makhetha MC, Jubilee M, Taole M, Nkomo C, Machinda A, Tlhomola M, Sande LA, Gomez Guillen GB, Corbett EL, Johnson CC, Hatzold K, Meyer-Rath G, Terris-Prestholt F. Using HIV self-testing to increase the affordability of community-based HIV testing services. AIDS. 2020 11 15; 34(14):2115-2123. PMID: 32796213; PMCID: PMC8425631; DOI: 10.1097/QAD.0000000000002664;
-
-
Jamieson L, Gomez GB, Rebe K, Brown B, Subedar H, Jenkins S, Shoko N, Bekker LG, Johnson LF, Meyer-Rath G. The impact of self-selection based on HIV risk on the cost-effectiveness of preexposure prophylaxis in South Africa. AIDS. 2020 05 01; 34(6):883-891. PMID: 32004205
-
Lince-Deroche N, Leuner R, Meyer-Rath G, Pillay Y, Long L. When donor funding leaves: an interrupted time-series analysis of the impact of integrating direct HIV care and treatment into public health services in a region of Johannesburg. Cost Eff Resour Alloc. 2019; 17:24.View Related Profiles. PMID: 31673249; PMCID: PMC6814986; DOI: 10.1186/s12962-019-0192-5;
-
Girdwood S, Govender K, Long L, Miot J, Meyer-Rath G. Primary healthcare delivery models for uninsured low-income earners during the transition to National Health Insurance: Perspectives of private South African providers. S Afr Med J. 2019 Sep 30; 109(10):771-783.View Related Profiles. PMID: 31635576
-
Johnson LF, van Rensburg C, Govathson C, Meyer-Rath G. Optimal HIV testing strategies for South Africa: a model-based evaluation of population-level impact and cost-effectiveness. Sci Rep. 2019 09 02; 9(1):12621. PMID: 31477764; PMCID: PMC6718403; DOI: 10.1038/s41598-019-49109-w;
-
Phillips AN, Cambiano V, Nakagawa F, Bansi-Matharu L, Wilson D, Jani I, Apollo T, Sculpher M, Hallett T, Kerr C, van Oosterhout JJ, Eaton JW, Estill J, Williams B, Doi N, Cowan F, Keiser O, Ford D, Hatzold K, Barnabas R, Ayles H, Meyer-Rath G, Nelson L, Johnson C, Baggaley R, Fakoya A, Jahn A, Revill P. Cost-per-diagnosis as a metric for monitoring cost-effectiveness of HIV testing programmes in low-income settings in southern Africa: health economic and modelling analysis. J Int AIDS Soc. 2019 07; 22(7):e25325. PMID: 31287620; PMCID: PMC6615491; DOI: 10.1002/jia2.25325;
-
Meyer-Rath G, van Rensburg C, Chiu C, Leuner R, Jamieson L, Cohen S. The per-patient costs of HIV services in South Africa: Systematic review and application in the South African HIV Investment Case. PLoS One. 2019; 14(2):e0210497. PMID: 30807573; PMCID: PMC6391029; DOI: 10.1371/journal.pone.0210497;
-
Campos NG, Lince-Deroche N, Chibwesha CJ, Firnhaber C, Smith JS, Michelow P, Meyer-Rath G, Jamieson L, Jordaan S, Sharma M, Regan C, Sy S, Liu G, Tsu V, Jeronimo J, Kim JJ. Cost-Effectiveness of Cervical Cancer Screening in Women Living With HIV in South Africa: A Mathematical Modeling Study. J Acquir Immune Defic Syndr. 2018 10 01; 79(2):195-205. PMID: 29916959; PMCID: PMC6143200; DOI: 10.1097/QAI.0000000000001778;
-
Meyer-Rath G, McGillen JB, Cuadros DF, Hallett TB, Bhatt S, Wabiri N, Tanser F, Rehle T. Targeting the right interventions to the right people and places: the role of geospatial analysis in HIV program planning. AIDS. 2018 05 15; 32(8):957-963. PMID: 29547437; PMCID: PMC5965918; DOI: 10.1097/QAD.0000000000001792;
-
Quaife M, Terris-Prestholt F, Eakle R, Cabrera Escobar MA, Kilbourne-Brook M, Mvundura M, Meyer-Rath G, Delany-Moretlwe S, Vickerman P. The cost-effectiveness of multi-purpose HIV and pregnancy prevention technologies in South Africa. J Int AIDS Soc. 2018 03; 21(3). PMID: 29537654; PMCID: PMC5851344; DOI: 10.1002/jia2.25064;
-
-
-
Nichols BE, Meyer-Rath G. Cost-effectiveness of early identification of HIV infection. Lancet HIV. 2017 10; 4(10):e431-e432.View Related Profiles. PMID: 28768605
-
-
Mikkelsen E, Hontelez JA, Jansen MP, Bärnighausen T, Hauck K, Johansson KA, Meyer-Rath G, Over M, de Vlas SJ, van der Wilt GJ, Tromp N, Bijlmakers L, Baltussen RM. Evidence for scaling up HIV treatment in sub-Saharan Africa: A call for incorporating health system constraints. PLoS Med. 2017 Feb; 14(2):e1002240. PMID: 28222126; PMCID: PMC5319640; DOI: 10.1371/journal.pmed.1002240;
-
-
Shearer K, Clouse K, Meyer-Rath G, MacLeod W, Maskew M, Sanne I, Long L, Fox MP. Citizenship status and engagement in HIV care: an observational cohort study to assess the association between reporting a national ID number and retention in public-sector HIV care in Johannesburg, South Africa. BMJ Open. 2017 Jan 24; 7(1):e013908.View Related Profiles. PMID: 28119389; PMCID: PMC5278236; DOI: 10.1136/bmjopen-2016-013908;
-
Johnson LF, Chiu C, Myer L, Davies MA, Dorrington RE, Bekker LG, Boulle A, Meyer-Rath G. Prospects for HIV control in South Africa: a model-based analysis. Glob Health Action. 2016; 9:30314. PMID: 27282146; PMCID: PMC4901512; DOI: 10.3402/gha.v9.30314;
-
Stover J, Bollinger L, Izazola JA, Loures L, DeLay P, Ghys PD. What Is Required to End the AIDS Epidemic as a Public Health Threat by 2030? The Cost and Impact of the Fast-Track Approach. PLoS One. 2016; 11(5):e0154893. PMID: 27159260; PMCID: PMC4861332; DOI: 10.1371/journal.pone.0154893;
-
Blecher M, Meyer-Rath G, Chiu C, Pillay Y, Abdullah F, Kollipara A, Daven J, Borowitz M, Tavanxi N. South African Health Review 2015/16. HIV/AIDS financing in South Africa: Sustainability and fiscal space. Health Systems Trust. Durban. 2016.
-
Johnson LF, Chiu C, Myer L, Davies MA, Dorrington RE, Bekker LG, Boulle A, Meyer-Rath G. Prospects for HIV control in South Africa: a model-based analysis. Glob Health Action. 2016 Jan; 9(1):30314. PMID: 28157035; DOI: 10.3402/gha.v9.30314;
-
Meyer-Rath G, Pienaar J, Brink B, van Zyl A, Muirhead D, Grant A, Churchyard G, Watts C, Vickerman P. The Impact of Company-Level ART Provision to a Mining Workforce in South Africa: A Cost-Benefit Analysis. PLoS Med. 2015 Sep; 12(9):e1001869. PMID: 26327271; PMCID: PMC4556678; DOI: 10.1371/journal.pmed.1001869;
-
Siegel G, Meyer-Rath G, Ermilova E, Rodríguez M, Malmsten M, Claesson P, Saunders R, Hetzer H, Lindman B. Flow Sensing in the Cardiovascular System. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2015; 480:318-327.
-
-
Iyer HS, Scott CA, Lembela Bwalya D, Meyer-Rath G, Moyo C, Bolton Moore C, Larson BA, Rosen S. Resource Utilization and Costs of Care prior to ART Initiation for Pediatric Patients in Zambia. AIDS Res Treat. 2014; 2014:235483.View Related Profiles. PMID: 24711925; PMCID: PMC3966317; DOI: 10.1155/2014/235483;
-
Terris-Prestholt F, Foss AM, Cox AP, Heise L, Meyer-Rath G, Delany-Moretlwe S, Mertenskoetter T, Rees H, Vickerman P, Watts CH. Cost-effectiveness of tenofovir gel in urban South Africa: model projections of HIV impact and threshold product prices. BMC Infect Dis. 2014; 14:14. PMID: 24405719; PMCID: PMC3899035; DOI: 10.1186/1471-2334-14-14;
-
Eaton JW, Menzies NA, Stover J, Cambiano V, Chindelevitch L, Cori A, Hontelez JA, Humair S, Kerr CC, Klein DJ, Mishra S, Mitchell KM, Nichols BE, Vickerman P, Bakker R, Bärnighausen T, Bershteyn A, Bloom DE, Boily MC, Chang ST, Cohen T, Dodd PJ, Fraser C, Gopalappa C, Lundgren J, Martin NK, Mikkelsen E, Mountain E, Pham QD, Pickles M, Phillips A, Platt L, Pretorius C, Prudden HJ, Salomon JA, van de Vijver DA, de Vlas SJ, Wagner BG, White RG, Wilson DP, Zhang L, Blandford J, Meyer-Rath G, Remme M, Revill P, Sangrujee N, Terris-Prestholt F, Doherty M, Shaffer N, Easterbrook PJ, Hirnschall G, Hallett TB. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. Lancet Glob Health. 2014 Jan; 2(1):e23-34.View Related Profiles. PMID: 25104632; DOI: 10.1016/S2214-109X(13)70172-4;
-
Eaton JW, Menzies NA, Stover J, Cambiano V, Chindelevitch L, Cori A, Hontelez JA, Humair S, Kerr CC, Klein DJ, Mishra S, Mitchell KM, Nichols BE, Vickerman P, Bakker R, Bärnighausen T, Bershteyn A, Bloom DE, Boily MC, Chang ST, Cohen T, Dodd PJ, Fraser C, Gopalappa C, Lundgren J, Martin NK, Mikkelsen E, Mountain E, Pham QD, Pickles M, Phillips A, Platt L, Pretorius C, Prudden HJ, Salomon JA, van de Vijver DA, de Vlas SJ, Wagner BG, White RG, Wilson DP, Zhang L, Blandford J, Meyer-Rath G, Remme M, Revill P, Sangrujee N, Terris-Prestholt F, Doherty M, Shaffer N, Easterbrook PJ, Hirnschall G, Hallett TB. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. Lancet Glob Health. 2013 Dec 10; 2(1):23-34.View Related Profiles. PMID: 25083415; PMCID: PMC4114402; DOI: 10.1016/S2214-109X(13)70172-4;
-
Schnippel K, Long L, Meyer-Rath G, Sanne I, Rosen S, Stevens W. Impact and costs of algorithms for the diagnosis of adults with pulmonary tuberculosis in South Africa. S Afr Med J. 2013 Jul; 103(7):436.View Related Profiles. PMID: 23946950
-
Scott CA, Iyer H, Bwalya DL, McCoy K, Meyer-Rath G, Moyo C, Bolton-Moore C, Larson B, Rosen S. Retention in care and outpatient costs for children receiving antiretroviral therapy in Zambia: a retrospective cohort analysis. PLoS One. 2013; 8(6):e67910.View Related Profiles. PMID: 23840788; PMCID: PMC3695874; DOI: 10.1371/journal.pone.0067910;
-
Meyer-Rath G, Brennan AT, Fox MP, Modisenyane T, Tshabangu N, Mohapi L, Rosen S, Martinson N. Rates and cost of hospitalization before and after initiation of antiretroviral therapy in urban and rural settings in South Africa. J Acquir Immune Defic Syndr. 2013 Mar 1; 62(3):322-328.View Related Profiles. PMID: 23187948; PMCID: PMC3625673; DOI: 10.1097/QAI.0b013e31827e8785;
-
Schnippel K, Meyer-Rath G, Long L, Stevens WS, Sanne I, Rosen S. Diagnosing Xpert MTB/RIF negative TB: impact and cost of alternative algorithms for South Africa. S Afr Med J. 2013 Feb; 103(2):101-6.View Related Profiles. PMID: 23374320; DOI: 10.7196/samj.6182;
-
-
Meyer-Rath G, Miners A, Santos AC, Variava E, Venter WD. Cost and resource use of patients on antiretroviral therapy in the urban and semiurban public sectors of South Africa. J Acquir Immune Defic Syndr. 2012 Nov 1; 61(3):e25-32. PMID: 22895437; DOI: 10.1097/QAI.0b013e31826cc575;
-
Kranzer K, Lawn SD, Meyer-Rath G, Vassall A, Raditlhalo E, Govindasamy D, van Schaik N, Wood R, Bekker LG. Feasibility, yield, and cost of active tuberculosis case finding linked to a mobile HIV service in Cape Town, South Africa: a cross-sectional study. PLoS Med. 2012; 9(8):e1001281. PMID: 22879816; PMCID: PMC3413719; DOI: 10.1371/journal.pmed.1001281;
-
Meyer-Rath G, Over M. HIV treatment as prevention: modelling the cost of antiretroviral treatment--state of the art and future directions. PLoS Med. 2012; 9(7):e1001247. PMID: 22802731; PMCID: PMC3393674; DOI: 10.1371/journal.pmed.1001247;
-
-
-
-
Vickerman P, Devine A, Foss AM, Delany-Moretlwe S, Mayaud P, Meyer-Rath G. The cost-effectiveness of herpes simplex virus-2 suppressive therapy with daily aciclovir for delaying HIV disease progression among HIV-1-infected women in South Africa. Sex Transm Dis. 2011 May; 38(5):401-9. PMID: 21317689; DOI: 10.1097/OLQ.0b013e31820b8bc8;
-
McCarthy K, Chersich MF, Vearey J, Meyer-Rath G, Jaffer A, Simpwalo S, Venter WD. Good treatment outcomes among foreigners receiving antiretroviral therapy in Johannesburg, South Africa. Int J STD AIDS. 2009 Dec; 20(12):858-62. PMID: 19948901; DOI: 10.1258/ijsa.2009.009258;
-
Renaud A, Basenya O, de Borman N, Greindl I, Meyer-Rath G. The cost effectiveness of integrated care for people living with HIV including antiretroviral treatment in a primary health care centre in Bujumbura, Burundi. AIDS Care. 2009 Nov; 21(11):1388-94. PMID: 20024715; DOI: 10.1080/09540120902884042;
-
Meyer-Rath G. The cost effectiveness of HIV control: Getting the priorities right. Southern African Journal of HIV Medicine. 2007; 28:15-16.
-
Meyer-Rath G, Marlise Richter. User fees, transport cost, and the ethics of exemption: How free is free ART?. Southern African Journal of HIV Medicine. 2007; 28:52-56.
-
Boehme C, Meyer-Rath G, Keitzer R, Luck W. Abdominal tuberculosis in children. Monatsschr Kinderheilkunde. 2007; 155:S16-S19.
-
Siegel S, Malmsten M, Fischer M, Meyer-Rath G, Hiemann N, Hetzer R. The role of the proteoglycan receptor in lipoprotein binding. Int J Angiol. 2003; 12:1-7.
This graph shows the total number of publications by year, by first, middle/unknown,
or last author.
| Year | Publications |
|---|
| 2003 | 1 |
| 2007 | 3 |
| 2009 | 2 |
| 2011 | 1 |
| 2012 | 6 |
| 2013 | 7 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 7 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 3 |
| 2021 | 12 |
| 2022 | 9 |
| 2023 | 8 |
2010 International AIDS Society/ ANRS:
Young Investigator Award